Navigation Links
Tuberculosis Immunotherapy Grant for Immunoxel Honibe Honey Lozenges
Date:2/3/2013

Kiev, Ukraine (PRWEB) February 02, 2013

Ekomed company is pleased to announce that Immunoxel formulated into Honey Lozenges™ has been awarded Global Science & Technology Entrepreneurship Program (STEP) grant from the Civilian Research & Development Foundation (CRDF). CRDF is the non-profit organization authorized by the US Congress and established in 1995 by the National Science Foundation. STEP is funded by the US Department of State and in part by the State Agency of Ukraine for Science, Innovation, and Information. The grant will support clinical trial and joint marketing initiative of honey-formulated herbal supplement, Immunoxel, shown clinically effective as an immune adjunct against tuberculosis.

TB is a global killer. According to the WHO two billion people or 1/3 of the global population is latently infected with Mycobacterium tuberculosis. Annually, nearly 9 million of these people develop active TB and 2 million die. Current tuberculosis drugs are 50 years old, not very effective, must be taken for 6-9 months for drug-sensitive TB and up to 36 months for drug-resistant strains - MDR-TB and XDR-TB. Thus, new alternative approaches are urgently needed. One of them is immunotherapy, which is believed to enhance the efficacy of chemotherapy and shorten treatment duration.

The proprietary water-alcohol phytoconcentrate of 25 herbs, Immunoxel (Dzherelo), was developed by Ukrainian company Ekomed in 1997. This herbal tincture is widely available in Ukrainian pharmacies and has been used as an immune supplement to treat various infectious diseases such as seasonal flu, TB and HIV. Published studies spanning over the past 15 years count nearly tw
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vaccination reduces the risk of unvaccinated badger cubs testing tuberculosis positive
2. From the mouths of monkeys: Swab technique spots tuberculosis in non-human primates
3. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
4. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
5. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
6. Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team
7. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
8. OsteoVantage™ Receives Grant from the National Science Foundation
9. Boyd Coatings Awarded Workforce Training Grant
10. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
11. University of Minnesota awarded $28 million grant to lead microelectronics development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global Human Albumin Industry Report 2014" report to ... Industry Report 2014 is a professional and in-depth study ... industry. The report provides a basic overview ... chain structure. The human albumin market analysis is provided ...
(Date:9/18/2014)... 18, 2014 Leatherwood Plastics has ... material, to stay competitive in the semiconductor, clean ... materials ultimately impact product quality and productivity, according ... , Established in 1980 in Lewisville, TX, ... fabricators have left the business. Much of Leatherwood’s ...
(Date:9/18/2014)... 18, 2014  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at BioCentury,s NewsMakers in the Biotech Industry conference ... from the Millennium Broadway Hotel & Conference Center in ... presentation can be accessed at www.meipharma.com . A replay ...
(Date:9/18/2014)... 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY ... but separate underwritten offerings of 10,000,000 shares of its ... $2.00 per share, for expected gross proceeds of $20 ... Preferred Stock at a price to the public of ... million. Each share of Series A Convertible Preferred Stock ...
Breaking Biology Technology:Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3
... For low-throughput disruption of a wide range of biological samples , ... , , ... of biological samples, including animal,and human tissues and cells and plant tissue. , ... The TissueRuptor system provides: , ...
... , ... and easy silica-based DNA purification in convenient spin-column and 96-well-plate,formats. Most ... for mechanical disruption and reducing,hands-on time. Optimized protocols for specific sample ... veterinary pathogen research applications. , ...
... Tracy Worzella and Brad Larson , Promega Corporation, Madison, WI, USA ... Application Note 138 ... , , Correlated measurement of ... Monitoring of both luminescence and fluorescence output signals from , one assay ...
Cached Biology Technology:TissueRuptor System 2TissueRuptor System 3DNA purification from pig ears to bird blood using proven DNeasy Technology 2Promegas Multiplexed Cell Viability and Apoptosis Assays performed on the PHERAstar 2Promegas Multiplexed Cell Viability and Apoptosis Assays performed on the PHERAstar 3Promegas Multiplexed Cell Viability and Apoptosis Assays performed on the PHERAstar 4Promegas Multiplexed Cell Viability and Apoptosis Assays performed on the PHERAstar 5
(Date:9/18/2014)... Mass. A novel robotic system that can operate ... being tested as part of a biomedical research partnership ... the aim of determining if the robot, in conjunction ... faster, more accurate, less costly, and less discomforting for ... to deliver prostate cancer therapies with greater precision. , ...
(Date:9/18/2014)... starts a "frequent flyers" program, fruit flies surely would ... has hosted increasing numbers of fruit fly research studies. ... in April, and another is scheduled launch to the ... launch in December. , Fruit flies are biomedical research ... space. Model organisms can reveal the basis for health ...
(Date:9/18/2014)... foliage season that prompts millions of Americans to undertake jaunts ... possibly last a little longer within a century, according to ... in some areas of the United States as summer temperatures ... the journal Global Ecology and Biogeography . For instance, ... the state tree of New Hampshire could change color ...
Breaking Biology News(10 mins):Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4
... PARK, Md. There,s no "silver bullet" for ... policies, but they do need reforming, says University ... testified today before the Senate Armed Services Committee. ... operation during the Clinton administration and has served ...
... one in 3,500 people are affected with retinitis pigmentosa ... eventually leads to blindness. Now, a University of Missouri ... humans for two different forms of RP. This discovery ... both cats and humans. "The ...
... of our bodies, could lead to remarkable advances in the ... organised by the European Science Foundation was told. The ... in Granada, Spain, on 23 February 2009, was part of ... research in Europe in recognition of the potential of RNA ...
Cached Biology News:Reforming defense department acquisition policy: UM expert 2Cats' eye diseases genetically linked to diseases in humans 2RNA research strategy for Europe takes shape 2
Mouse anti-hepatitis delta virus Class: Antibody Product Group: Bacterial and Viral Antigen...
Mouse monoclonal [YLI-90] to Ly49I (Biotin) ( Abpromise for all tested applications)....
Rabbit polyclonal to KIAA1276 ( Abpromise for all tested applications). entrezGeneID: 27146 SwissProtID: Q9ULE4...
Rabbit polyclonal to IL23 P19 ( Abpromise for all tested applications). Antigen: Synthetic 16 amino acid peptide from near the amino terminus of human IL23 P19 Entrez Gene ID: 51561 Swiss...
Biology Products: